6 resultat
BACKGROUND OF THE INVENTION
The present invention relates to the treatment of certain conditions using a compound of formula I or II, or a pharmaceutically acceptable salt thereof, as defined below. Specifically, the compounds of formulas I and II, and their pharmaceutically acceptable salts, as
BACKGROUND OF THE INVENTION
The present invention is novel compounds which are 4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidine substituted 1,2,4- and 1,3,4-thiadazoles and oxadiazoles, and 1,2,4-triazoles, and pharmaceutically acceptable acid addition or base salts thereof, pharmaceutical
TECHNICAL FIELD
The present invention relates generally to a method of modulating substance P by compounds containing calcium sulfate, particularly syngenite, gorgeyite and gypsum, and more specifically, to the synthesis of such compounds as well as their use to treat a variety of conditions
FIELD OF THE INVENTION
The present invention relates to the field of a method of therapy of a condition known as oral herpes simplex which manifests itself as an ulceration of the type that appear in or near the mouth or in other mucous membrances, including such conditions as canker sores, cold
This is a continuation in-part of PCT/JP90/00905, filed Jul. 12, 1990.
FIELD OF THE INVENTION
The present invention relates to a novel styryl compound, a pharmaceutically acceptable salt thereof or an ester thereof which possesses leukotriene-antagonistic actions and inhibitory actions against
BACKGROUND OF THE INVENTION
The present invention is novel compounds which are 4,6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidine substituted 1,2,4- and 1,3,4-thiadazoles and oxadiazoles, and 1,2,4-triazoles, and pharmaceutically acceptable acid addition or base salts thereof, pharmaceutical